O2 Muu julkaisu

Highlight selection of radiochemistry and radiopharmacy developments by editorial board



Tekijät: Toyohara, Jun; Elsinga, Philipp H.; Todde, Sergio; Li, Xiang-Guo; Aime, Silvio; Szymanski, Wictor C.; van der Meulen, Nick; Cleeren, Frederik; Schirrmacher, Ralf; Yang, Hua; Savio, Eduardo; Bentaleb, Naoual; Zubillaga, Marcela; Chaple Gore, Ivis F.; Bourgeois, Mickaël; Mukherjee, Archana; Pellico, Juan; Kopka, Klaus

Kustantaja: Springer Nature

Julkaisuvuosi: 2025

Lehti:: EJNMMI Radiopharmacy and Chemistry

Artikkelin numero: 65

Vuosikerta: 10

eISSN: 2365-421X

DOI: https://doi.org/10.1186/s41181-025-00387-y

Verkko-osoite: https://doi.org/10.1186/s41181-025-00387-y

Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/504678610


Tiivistelmä
Background

The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development and application of radiopharmaceuticals.

Main Body

This selection of highlights provides commentary on 18 different topics selected by each co-authoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals.

Conclusion

Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.


Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.

Julkaisussa olevat rahoitustiedot: 
Open Access funding enabled and organized by Projekt DEAL.


Last updated on 2025-23-10 at 15:03